While diabetes and obesity remain the primary targets, emerging research into new indications offers a transformational opportunity for market growth
Yoon, Mimi Kim, Dae Won Jun Clinical Gastroenterology and Hepatology .2026;[Epub] CrossRef Progression of Metabolic DysfunctionAssociated Steatohepatitis in US Adults Using Linked Records and Claims Yestle Kim, Romina Fakhraei, John C
As studies evolve, new dosage recommendations may emerge
People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) or with a personal or family history of medullary thyroid carcinoma (MTC) should not use semaglutide
Semaglutide patients often report that their stomach signals fullness differently than before treatmentstopping at 60-70% fullness prevents the overstuffed sensation that triggers nausea
Smoke and hormone mirrors: action and evolution of karrikin and strigolactone signaling